These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25285240)

  • 1. A Proposal for an Individualized Pharmacogenetic-Guided Warfarin Dosage Regimen for Puerto Rican Patients Commencing Anticoagulation Therapy.
    Bosch LA
    J Pharmacogenomics Pharmacoproteomics; 2014 Jan; 5(1):. PubMed ID: 25285240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
    Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
    Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.
    Valentin II; Vazquez J; Rivera-Miranda G; Seip RL; Velez M; Kocherla M; Bogaard K; Cruz-Gonzalez I; Cadilla CL; Renta JY; Feliu JF; Ramos AS; Alejandro-Cowan Y; Gorowski K; Ruaño G; Duconge J
    Ann Pharmacother; 2012 Feb; 46(2):208-18. PubMed ID: 22274142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Utility Study of Warfarin Genotyping in the VACHS Affiliated Anticoagulation Clinic of Puerto Rico.
    Martes-Martinez C; Méndez-Sepúlveda C; Millán-Molina J; French-Kim M; Marín-Centeno H; Rivera-Miranda GC; Hernández-Muñoz JJ; Duconge-Soler J
    P R Health Sci J; 2017 Sep; 36(3):165-172. PubMed ID: 28915306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of genotype-guided dosing of warfarin.
    Pirmohamed M; Burnside G; Eriksson N; Jorgensen AL; Toh CH; Nicholson T; Kesteven P; Christersson C; Wahlström B; Stafberg C; Zhang JE; Leathart JB; Kohnke H; Maitland-van der Zee AH; Williamson PR; Daly AK; Avery P; Kamali F; Wadelius M;
    N Engl J Med; 2013 Dec; 369(24):2294-303. PubMed ID: 24251363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient: Role of a Novel
    Hernandez-Suarez DF; Claudio-Campos K; Mirabal-Arroyo JE; Torres-Hernández BA; López-Candales A; Melin K; Duconge J
    J Investig Med High Impact Case Rep; 2016; 4(4):2324709616682049. PubMed ID: 28210634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients.
    Ramos AS; Seip RL; Rivera-Miranda G; Felici-Giovanini ME; Garcia-Berdecia R; Alejandro-Cowan Y; Kocherla M; Cruz I; Feliu JF; Cadilla CL; Renta JY; Gorowski K; Vergara C; Ruaño G; Duconge J
    Pharmacogenomics; 2012 Dec; 13(16):1937-50. PubMed ID: 23215886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Dowd MB; Subherwal S; Deych E; Eby CS; King CR; Porche-Sorbet RM; Murphy CV; Marchand R; Millican EA; Barrack RL; Clohisy JC; Kronquist K; Gatchel SK; Gage BF
    J Thromb Haemost; 2008 Oct; 6(10):1655-62. PubMed ID: 18662264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.
    Syn NL; Wong AL; Lee SC; Teoh HL; Yip JWL; Seet RC; Yeo WT; Kristanto W; Bee PC; Poon LM; Marban P; Wu TS; Winther MD; Brunham LR; Soong R; Tai BC; Goh BC
    BMC Med; 2018 Jul; 16(1):104. PubMed ID: 29986700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.
    Carcas AJ; Borobia AM; Velasco M; Abad-Santos F; Díaz MQ; Fernández-Capitán C; Ruiz-Giménez N; Madridano O; Sillero PL;
    Trials; 2012 Dec; 13():239. PubMed ID: 23237631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
    Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
    Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups.
    Dietz N; Ruff C; Giugliano RP; Mercuri MF; Antman EM
    Int J Cardiol; 2020 Oct; 317():159-166. PubMed ID: 32505370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population.
    Ren Y; Yang C; Chen H; Dai D; Wang Y; Zhu H; Wang F
    Front Pharmacol; 2020; 11():1014. PubMed ID: 32754031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
    Avery PJ; Jorgensen A; Hamberg AK; Wadelius M; Pirmohamed M; Kamali F;
    Clin Pharmacol Ther; 2011 Nov; 90(5):701-6. PubMed ID: 22012312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.
    Leary E; Brilliant M; Peissig P; Griesbach S
    Am J Health Syst Pharm; 2019 Feb; 76(6):387-397. PubMed ID: 31415684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
    Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
    Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic versus clinical dosing of warfarin in individuals of Chinese and African-American ancestry: assessment using data simulation.
    Syn NL; Lee SC; Brunham LR; Goh BC
    Pharmacogenet Genomics; 2015 Oct; 25(10):491-500. PubMed ID: 26230382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
    Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
    J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans.
    Valentín II; Rivera G; Nieves-Plaza M; Cruz I; Renta JY; Cadilla CL; Feliu JF; Seip RL; Ruaño G; Duconge J
    P R Health Sci J; 2014 Sep; 33(3):97-104. PubMed ID: 25244877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.